Cannabipiperidiethanone

Source: Wikipedia, the free encyclopedia.
Cannabipiperidiethanone
Legal status
Legal status
Identifiers
  • 2-(2-Methoxyphenyl)-1-[1-([1-methylpiperidin-2-yl]methyl)indol-3-yl]ethanone
JSmol)
SMILES
  • COc2ccccc2CC(=O)c(c4c1cccc4)cn1CC3CCCCN3C
  • InChI=1S/C24H28N2O2/c1-25-14-8-7-10-19(25)16-26-17-21(20-11-4-5-12-22(20)26)23(27)15-18-9-3-6-13-24(18)28-2/h3-6,9,11-13,17,19H,7-8,10,14-16H2,1-2H3
  • Key:AJSBNWAHEDVQJT-UHFFFAOYSA-N

Cannabipiperidiethanone (CPE or 1-(N-methylpiperidin-2-ylmethyl)-3-(2-methoxyphenylacetyl)indole) is a

synthetic cannabis blends sold in Japan, alongside JWH-122 and JWH-081
.

Its binding affinity was measured at the

CB2 receptors and it was found to have an IC50 of 591 nM at CB1 and 968 nM at CB2, making it 2.3 times and 9.4 times weaker than JWH-250 at these two targets respectively.[1]

In the

Schedule I Controlled Substances.[2]

See also

References

  1. PMID 21881274
    .
  2. ^ 21 U.S.C. § 812: Schedules of controlled substances
Retrieved from "https://en.wikipedia.org/w/index.php?title=Cannabipiperidiethanone&oldid=1268767407"